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Abstract The mechanism of viral persistence, the driving
force behind the chronic progression of inflammatory
demyelination in canine distemper virus (CDV) infection, is
associated with non-cytolytic viral cell-to-cell spread. Here,
we studied the molecular mechanisms of viral spread of a
recombinant fluorescent protein-expressing virulent CDV
in primary canine astrocyte cultures. Time-lapse video
microscopy documented that CDV spread was very efficient
using cell processes contacting remote target cells.
Strikingly, CDV transmission to remote cells could occur in
less than 6 h, suggesting that a complete viral cycle with
production of extracellular free particles was not essential in
enabling CDV to spread in glial cells. Titration experiments
and electron microscopy confirmed a very low CDV particle
production despite higher titers of membrane-associated
viruses. Interestingly, confocal laser microscopy and lenti-
virus transduction indicated expression and functionality of
the viral fusion machinery, consisting of the viral fusion (F)
and attachment (H) glycoproteins, at the cell surface.
Importantly, using a single-cycle infectious recombinant H-
knockout, H-complemented virus, we demonstrated that H,
and thus potentially the viral fusion complex, was necessary
to enable CDV spread. Furthermore, since we could not
detect CD150/SLAM expression in brain cells, the presence
of a yet non-identified glial receptor for CDV was suggested.
Altogether, our findings indicate that persistence in CDV
infection results from intracellular cell-to-cell transmission
requiring the CDV-H protein. Viral transfer, happening
selectively at the tip of astrocytic processes, may help the
virus to cover long distances in the astroglial network,
‘‘outrunning’’ the host’s immune response in demyelinating
plaques, thus continuously eliciting new lesions.
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Introduction
Canine distemper virus (CDV) is an enveloped, non-
segmented, negative-stranded RNA morbillivirus, closely
related to measles virus (MV) and belongs to the family of
the Paramyxoviridae [18]. Brain infection with CDV
induces a chronic demyelinating disease which is consid-
ered to be a model for multiple sclerosis (MS) [36]. An
infectious cause of MS, the most important inflammatory
demyelinating disease in human, is suggested by epide-
miological data but remains elusive [15]. White matter
destruction in MS results from the inflammatory response,
which is thought to be associated with autoimmunity
against myelin antigens [19], but there is also evidence
for intrathecal production of anti-viral antibodies [2]. In
animal models of viral-induced demyelination, such as
distemper, inflammatory white matter lesions result at least
in part from the intrathecal immune response against the
virus, which in the case of CDV infects predominantly
astrocytes [39, 43]. However, previous studies performed
with CDV have demonstrated that despite effective clear-
ance of the virus in inflammatory lesions in the white
matter of infected dogs [1], the virus has the ability to
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spread to other areas of the central nervous system (CNS),
ever eliciting new lesions [39]. Thus, viral persistence is
the driving force behind the progression of the disease [29].
Unraveling the molecular mechanisms of viral persistence
is therefore the key to understand the pathogenesis of
chronic progressive inflammatory demyelination.
How CDV can establish a persistent infection in the CNS
is poorly understood. Production of defective viruses such
as in persistent CNS infection by the closely related MV in
humans [29] does not occur in distemper [24]. Tissue cul-
ture studies suggested that virulent CDV shares the ability
with MV to spread from cell-to-cell [43], a mechanism
which may shield the infection from immune detection [34].
While cell-to-cell spread in models of MV infection occurs
in neurons [21], CDV primarily infects astrocytes of the
white matter [39, 44]. Our previous work suggested that
viral persistence mediated by A75/17-CDV (a highly neu-
rovirulent and demyelinating strain) in dog brain cell
cultures (DBCCs) was characterized by a non-cytolytic
infection with limited production of extracellular viral
particles. Infected cells were widely spaced but seemed to
be in contact with each other by their processes thus indi-
cating cell-to-cell spread [43, 44]. These findings were
suggestive of a different mechanism of viral transmission of
persistent CDV as compared to cytolytic CDV strains.
In the present study, we infected primary canine brain
cell cultures with a recombinant red fluorescent protein
(RFP)-expressing wild-type Morbillivirus strain (rA75/
17red) to investigate the mechanism of persistent CDV
infection. Fluorescent protein-expressing CDV strains have
been used before in vitro [25] as well as in vivo [32, 40].
Our results indicated that spread of persistent CDV in
astrocytes did not require infectious particles, whereas the
viral attachment protein was crucial in allowing lateral
cell-to-cell transmission most likely by mediating cell–cell
fusion activity. Furthermore, we found that viral spread to
neighboring cells could occur in very short time, support-
ing the notion that lateral cell-to-cell transmission of CDV
in brain cells is highly efficient.
Materials and methods
Cells and viruses
Primary DBCCs were prepared as previously described
[44]. Vero-SLAM cells (kindly provided by V. von Messling,
INRS-Institut Armand-Frappier, University of Quebec,
Laval, Quebec, Canada) were grown in multiwell plates,
for some experiments with coverslips attached to the bot-
tom of the wells. Tissue culture medium consisted of
Dulbecco’s modified Eagle medium (DMEM, Invitrogen)
supplemented with 10% fetal calf serum (FCS), penicillin
and streptomycin. The selection of Vero cells expressing
the SLAM receptor was maintained by adding ZeocinTM
(Invitrogen). Cells were kept at 37C in the presence of 5%
CO2. The recombinant (rA75/17
red) virus contains an
additional red fluorescence marker gene (RFP: ‘‘tD-
tomato’’, a kind gift from D. Garcin, University of Geneva
[22]) located between the M and F genes (rA75/17red) and
was amplified in Vero-SLAM cells. The recombinant A75/
17 virus, containing an additional RFP gene and addi-
tionally knocked out for the hemagglutinin gene, was
amplified via trans-complementation with the wild-type
hemagglutinin protein (Hwt), in Vero-SLAM cells stably
expressing Hwt (rA75/17red Hko/Hcomp, allowing the gen-
eration of single-cycle infectious viruses).
Cultures of primary dog brain cells were infected as
soon as they reached confluency (which was between days
5 and 7 post-seeding) at an MOI of 0.01 (titrated in Vero-
SLAM cells) with rA75/17red for 2 h. In several experi-
ments, infected cultures were overlaid 1 day post-infection
(dpi) with medium containing soft agar (1%) to inhibit free
movement of extracellular viral particles.
Generation of CDV full-length cDNA clones
The plasmid containing the full-length cDNA clone of the
A75/17-CDV genome (pA75/17 [30]) was digested with
BstEII. A small linker containing the unique restriction site
ApaI was generated by annealing two single-stranded DNA
oligonucleotides and subsequently cloned into the BstEII-
cleaved pA75/17 plasmid. The RFP gene (tD-tomato,
kindly gift by D. Garcin, University of Geneva, Switzer-
land) was next amplified by conventional PCR technique
and cloned into the ApaI-cleaved vector, thus generating
pA75/17red. Next, plasmid pA75/17red was digested with
MluI and BssHII. Again, a small linker was generated by
annealing two single-stranded DNA oligonucleotides and
subsequently cloned into the cleaved pA75/17red plasmid,
thus generating pA75/17red-Hko. Both full-length cDNA
clones respect the rule of six [5]. Primer sequences are
available upon request. Viruses were rescued as previously
described [28] with minor modification in case of rA75/
17red/Hko/Hcomp, as detailed in ‘‘Results’’.
Generation of Hwt-expressing Vero-SLAM cells
(Vero-SLAM-H)
Vero-SLAM cells were transduced with pRRL lenti vectors
at an MOI of 5. Consequently, a Vero-SLAM-Hwt clone
was selected by limiting dilution and was used for further
experiments. Flow cytometry analysis using two confor-
mational epitope-recognizing anti-CDV-H MAbs (3900
[26] and 1C42H11, VMRD) were employed to confirm
Hwt expression at the cell surface.
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The lentivirus vector pRRL has been described else-
where [6], and kindly provided by Patrick Salomon,
University of Geneva). Stocks of lentivirus vectors were
generated in 293T/17 cells as previously described [6].
Confocal fluorescence microscopy and video
microscopy
Dog brain cell cultures infected with the rA75/17red were
examined by confocal fluorescence microscopy (Olympus)
at 3, 6, 9 and 12 dpi. At 3 dpi, several infected foci were
selected and their locations (x–y axis) were stored using a
coordination software package (Fluoview FV1000, Version
1.7b). At each consecutive time point, the identical foci
were thus tracked, photographed and the viral spreading
pattern analyzed.
For the life cell video imaging procedure, DBCCs were
placed in a life imaging system incubator chamber. Foci of
infection with rA75/17red in DBCCs were determined at
3 dpi. Images were taken at 1 h intervals from the same
infected foci during 72 h (Nikon TE2000E-PFS, Hamamatsu
ORCA-AR Camera, and Nikon NIS Elements Software).
Immunofluorescence
At 3, 6, 9 and 12 dpi, DBCCs on coverslips were washed with
PBS and subsequently fixed with PBS containing 4% para-
formaldehyde. Cells were washed, permeabilized with
normal goat sera 5% containing Triton-X 100 (0.5%) for
20 min and further blocked for 1 h with 5% goat sera in PBS.
Then, either one of the following primary antibodies was
added to the cells: mouse monoclonal anti-N (D110 [1]),
rabbit polyclonal anti-glial fibrillary acidic protein
(DAKO, Zug, Switzerland), rabbit polyclonal anti-canine
SLAM protein [42], mouse monoclonal anti-H glycoprotein
(3900 [26]) or mouse monoclonal anti-F (4068 [26]) glyco-
protein. Furthermore, in some experiments, the same
procedure was used to stain Vero and Vero-SLAM cell
cultures for assessing SLAM expression. As secondary
antibodies, either anti-mouse IgG (Alexa Fluor 488,
Invitrogen) or anti-rabbit IgG fluorescent antibodies (Alexa
Fluor 555, Invitrogen) were employed. In addition,
Toto-3 iodide (Invitrogen) was added for nuclear staining.
Electron microscopy
Material from a previous experiment designed to study oli-
godendroglial pathology in CDV infection was re-examined.
Briefly, A75/17-CDV-infected DBCCs grown in petri dishes
had been harvested at various intervals post-infection, fixed
with glutaraldehyde, detached from the petri dish and pel-
leted by centrifugation. The pellets had been osmicated and
embedded in resin. Thin sections were examined with an
electron microscope. Representative areas had been photo-
graphed at various magnifications. These images were
re-evaluated in the present study specifically focusing on
morphological aspects of CDV replication especially
searching for signs of budding, viral particles, localization of
nucleocapsids and cell–cell membrane fusion.
RT-PCR
Total RNA extraction was performed from infected and
non-infected DBCCs, Vero or Vero-SLAM cells, using the
RNA extraction kit (Qiagen). Subsequently, reverse tran-
scription (Roche) and the PCR amplification (Roche) were
made according to the manufacturer’s instructions. The
primers used for SLAM and GAPDH amplification are
available upon request. Finally, PCR products were sub-
mitted to migration on a 1% gel agarose.
Growth kinetics and virus titration
To assess the growth kinetics of the viruses in DBCCs,
samples were taken at 3, 6, 9, 12 and 15 dpi. Titers of both
the cell-free (SN) and cell-associated (CA) viruses were
examined. Cell-free viruses were directly harvested from
the supernatant of infected cells, centrifuged at 2,000 rpm
and stored at -80C. Cell-associated viruses were released
by two cycle of freezing/thawing, centrifuged at 2,000 rpm
and subsequently stored at -80C. Titration experiments
were performed on Vero-SLAM cells by limiting dilution
assay, as previously described [27].
Generation of lentiviral vector expressing the CDV
receptor CD150/SLAM and Hwt
The lentivirus vector pRRL has been described elsewhere
([6], and was kindly provided by Patrick Salomon, Uni-
versity of Geneva). The SLAM gene was amplified by PCR
(Roche) and subsequently digested with RsrII and cloned
into the pRRL-RsrII-cleaved vector. Stock of lentivirus
vectors was generated in 293T/17 cells as previously
described [6]. The identical strategy was used to clone the
Hwt gene into the pRRL vector. Hwt was amplified by
conventional PCR technique (Roche) from the expression
vector pCI-Hwt [27].
Results
In primary DBCCs, the demyelinating A75/17-CDV
strain spreads from cell-to-cell in a selective manner
by way of cell processes
Primary DBCCs, mainly consisting of astrocytes, were
confluent 1 week after seeding. At that time point, they
Acta Neuropathol (2010) 119:617–630 619
123
were infected with the recombinant A75/17-CDV engi-
neered to express the RFP (rA75/17red) from an additional
transcription unit located between the M and F genes.
Foci of infection were identified 3 dpi and localized by
confocal laser scanning microscopy combined with a
coordinate software package allowing tracking identical
foci at consecutive time intervals. Selected foci were
photographed every 3 days. Figure 1a–d illustrates a
typical example of the evolution of one infected focus
over time. Infected cells and their finely branching pro-
cesses were outlined by the RFP and did not exhibit any
signs of syncytia formation and cytolysis. Infected foci
became steadily larger but generally with wide spacing
between infected and target cells, leaving immediately
surrounding neighboring cells uninfected. Importantly,
infected cells seemed always to be in contact with each
other by way of their processes. Confocal laser micro-
scopic images representing thin horizontal slices of the
culture often revealed continuity between infected cells
and processes (Fig. 1e, f). Immunofluorescence analysis
in rA75/17red-infected DBCCs, using an antibody against
the N protein of CDV, revealed perfect congruency of the
RFP with presence of the viral protein, thus excluding
passive diffusion of the RFP to non-infected cells
(Fig. 1g). In addition, immunofluorescence analysis indi-
cated that the main target of rA75/17red in DBCCs was
astrocytes (Fig. 1h), consistent with our previous reports
[39]. Furthermore, astrocytic processes could exhibit
positive particulate immunofluorescent signals when
stained with an anti-N (nucleoprotein) monoclonal anti-
body (MAb) (Fig. 1i, j), presumably representing viral
nucleocapsid aggregates.
To more accurately track non-cytolytic viral spread and
to visualize dynamic changes within short intervals, we
performed time-lapse video microscopy. To this aim,
3 days after initial infection, images were taken from
infected foci every hour during a period of 3 days. The
speed of intercellular viral transmission was highly vari-
able and appeared to take place in leaps and bounds.
Infected foci could remain quite stable for many hours or
even days and then suddenly start to spread to other cells in
a few hours. This is illustrated in Fig. 2, which shows an
example of rA75/17red cell-to-cell spread tracked with 1 h
intervals. The focus of infection started from two initially
infected cells, which were expressing RFP already at
72 hpi but with the infection remaining quite inactive until
90 hpi. Using this approach, it became clear that trans-
mission of the infection strictly implicated two contacting
cells and that the infection was transmitted by the tip of a
cell process from an infected cell contacting a target cell. In
the latter, fluorescence became first visible in the cell body
and later in the cell processes, which then transmitted the
infection to a third remote cell. Remarkably, time-lapse
video microscopy revealed in some foci that CDV could
spread to remote cells within a matter of 5–6 h (Fig. 2,
initial infected cell, red arrowhead; remotely infected cells,
yellow and blue arrowheads). This is much shorter as
compared to 24 h that are in general required for CDV to
produce free viral particles that can subsequently re-infect
a new cell [12].
The above results taken together suggest that, in primary
canine brain cells, the RFP-expressing recombinant CDV
spread laterally from cell-to-cell in a non-cytolytic and
selective manner by way of cell processes.
The canine CD150/SLAM receptor is not expressed
in DBCCs
To date, the CD150/SLAM receptor is the only known
receptor for virulent CDV [37, 38, 41]. Previous studies
suggested paucity of SLAM expression in brains of
uninfected dogs but that SLAM expression might be
upregulated in brain of dogs with distemper [42]. Since we
demonstrated that rA75/17red spread very efficiently in
DBCCs, we investigated whether SLAM was expressed
and/or upregulated in primary dog brain cells upon infec-
tion. Since SLAM detection by immunofluorescence
analysis remained repeatedly negative (data not shown), we
employed a more sensitive technique to monitor SLAM
expression. Thus, RT-PCRs from extracted DBCCs RNA
were performed from infected and non-infected cells at six
consecutive time points post-infection (0, 3, 6 and 9, 12
and 15 dpi). To validate our SLAM primers, RNAs extrac-
ted from Vero and Vero-SLAM cells served as negative
and positive control, respectively, and semi-quantitative
RT-PCRs were performed by including the analysis of the
housekeeping GAPDH gene. Figure 3 clearly documents
that SLAM mRNA was totally undetectable throughout the
whole course of a successful infection with rA75/17red in
DBCCs, whereas the GAPDH mRNA in the identical
samples was constantly detected, thereby validating our
semi-quantitative RT-PCR system. Combined, these results
not only demonstrate that the SLAM receptor was absent
from primary canine brain cells but that efficient infection
did not upregulate its expression.
Extremely limited free viral particle formation
and inefficient cell entry of rA75/17red in DBCCs
We then determined the kinetics of infectivity of rA75/
17red in DBCCs during a period of 2 weeks. In these series
of experiments, both cell-free (SN) and cell-associated
(CA) viruses were analyzed. Figure 4a illustrates the
kinetics of virus titers, which were determined in Vero-
SLAM cells. The titer of supernatant viral particles reached
a maximum of 10–30 infectious units per ml at day 9
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Fig. 1 Spread of rA75/17red in primary dog brain cell cultures
(DBCCs). a–d The recombinant A75/17-CDV, expressing an addi-
tional red fluorescent protein (rA75/17red), efficiently spreads in
DBCCs. A growing infected focus is shown at 3, 6, 9 and 12 dpi.
Asterisk depicts the same coordination point throughout the time of
infection. Red fluorescence emission outlines the whole infected cells
and their processes. Infected cells are widely spaced but seem always
in contact with each other by way of their processes. Confocal laser
microscopy 920. e rA75/17red-infected DBCCs are in contact through
thin cell processes (white arrowheads), as observed by the red
fluorescence emission. Confocal laser microscopy 9200. f Merged
images of CDV-induced red fluorescence emission and corresponding
DIC image demonstrating that the DBCCs are confluent with spread
of CDV from infected to target cells bypassing numerous uninfected
cells. Confocal laser microscopy 9200. g Merged images of CDV
nucleoproteins (N) labeled with a primary anti-N antibody, followed
by a secondary alexa fluor 488-conjugated antibody (green), with red
fluorescence emission in rA75/17red-infected cells (red) shows co-
localization of both labels (yellow) excluding passive diffusion of
RFP. Confocal laser microscopy 9200. h Astrocytes are the main
target of rA75/17red in DBCCs. Merged images of CDV-infected cells
by direct emission of red fluorescence (red) and astrocytes stained
with an anti-GFAP antibody, followed by a secondary alexa fluor
555-conjugated antibody. i The CDV nucleocapsids (green) are
located both in the cytosol and processes of infected astrocytes (red).
Merged images of CDV nucleoprotein (N) stained with an anti-N
antibody, followed by a secondary alexa fluor 488-conjugated
antibody and astrocytes stained with an anti-GFAP antibody,
followed by a secondary alexa fluor 555-conjugated antibody.
Confocal laser microscopy 9200. j 3D reconstruction of 30 Z
stacking images taken by confocal laser microscopy illustrating the
presence of CDV nucleocapsids [anti-N antibody staining, followed
by alexa fluor 488-conjugated antibody (green)] inside thin long
astrocytic processes [anti-GFAP antibody staining, followed by alexa
fluor 555-conjugated antibody (red)]. Confocal laser microscopy
91,000
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post-infection. This can be regarded as an insignificant
amount with respect to the much higher cell-associated
infectious titers (3 9 104). Next, we sought to determine
the entry efficiency of rA75/17red in cultured astrocytes by
infecting Vero-SLAM cells and DBCCs with an equal
amount of viruses (MOI of 0.01 as titrated in Vero-SLAM
cells). One day post-infection, the number of infected cells
per well were then counted. While infection of Vero-
SLAM cells with rA75/17red produced about 20,000
infected cells, only 200 were counted in DBCCs (Fig. 4b).
Thus, viral particles of the virulent virus entered glial cells
in a very inefficient manner as compared to cells express-
ing the canine CD150/SLAM receptor.
The results of titration and viral cell entry analyses
strongly argue against viral cell-to-cell transmission being
sustained by way of extracellular viral release. Moreover,
this conclusion was further supported by covering infected
DBCC with medium containing agar, limiting free move-
ment of released infectious particles. Despite mild
cytotoxicity of the agar overlay on brain cells, cell-to-cell
spread of rA75/17red in DBCCs remained efficient (not
shown). Finally, we searched for viral budding in astro-
cytes by electron microscopy, which is easily demonstrated
after infection with the highly cytolytic Onderstepoort
CDV strain [11]. Strikingly, however, viral budding was
extremely rare in case of rA75/17red-infected DBCCs,
confirming our titration assays in supernatants. Neverthe-
less, massive numbers of nucleocapsids were detected in
the cytosol of perikarya, cell processes and their finest
ramifications (Fig. 5a–f, white arrowheads). These nucle-
ocapsids were easily found as small and large aggregates of
typical tubular structures of the ‘‘fuzzy’’ type (Fig. 5a, b, e)
as described in the literature [3]. In such aggregates,
nucleocapsids were either surrounded by clear cytosol and
cell organelles (Fig. 5b, white arrowhead) or embedded in
a granular electron-dense matrix (Fig. 5c, d, white arrow-
heads). The latter type of inclusions was very often
attached to the plasma membrane (Fig. 5d, white arrow-
head). Occasionally, alignment of nucleocapsids along the
cell membrane could be observed as well as focal, some-
times discontinuous, plasmalemmal densities, reminiscent
Fig. 2 Video microscopy of DBCCs infected with rA75/17red.
Consecutive images of an infected focus taken at 1 h intervals (or
18 h; two first images). Red arrowhead depicts an infected cell at the
beginning of the sequence (72 h post-infection). From 90 hpi, the
infection is spreading to other cells by contact of cell processes in
various directions. Additional cells become fluorescent within inter-
vals of 1 h. The yellow arrowhead depicts one of these cells (91 hpi).
A process of the latter becomes fluorescent at 95 hpi. One hour later
(96 hpi), the latter is in contact with a process of an additional cell
(depicted by blue arrowhead), now becoming fluorescent. The last
image of the series (104 hpi) illustrates an overlay of the red
fluorescent protein with phase contrast showing a confluent culture,
thereby demonstrating that the infection spreads selectively bypassing
numerous cells which remain uninfected (940)
Fig. 3 The universal Morbillivirus CD150/SLAM receptor is not
expressed in primary canine brain cells. DBCCs were infected (or left
uninfected) with rA75/17red at an MOI of 0.01 (as titrated in Vero-
SLAM cells). Total RNA was then extracted and subjected to RT-
PCRs for assessing SLAM and the housekeeping gene GAPDH
expressions at the indicated days post-infection. In addition, total
RNA was extracted from Vero and Vero-SLAM cells to control for
any defect in the RT-PCR system. S SLAM gene, G GAPDH gene,
V Vero cells, V/S Vero-SLAM cells
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of insertion of viral surface proteins, described as ‘‘spik-
ing’’ (Fig. 5e, grey arrowheads), in cytolytic infection [12].
Thus, all these findings confirmed full replication of rA75/
17red in DBCCs but with extremely rare formation of viral
particles. Cell–cell fusion with formation of multinucleated
cells was not observed in the time frame of the experiments
described above. Focal blurring of the cell borders in two
opposing cytoplasmic membranes of infected cells was
sometimes seen (Fig. 5b, grey arrowhead, c, small white
arrowheads). Cell processes connecting infected cells
establishing continuity between them, as suggested by the
confocal laser microscopy images, were difficult to dem-
onstrate since the chance of finding two widely separated
cells with connecting cell processes in the same plane
of section at the ultrastructural level is extremely small.
Figure 5f is a composite image of four overlapping EM
photographs showing such a cell process (white arrows).
Taken together, these data support strong evidence that
rA75/17red non-cytolytic cell-to-cell spread in primary
canine brain cells is not mediated by viral free particle
formation but rather through direct contact with neigh-
boring cells associated with transfer of viral nucleocapsids.
Both viral surface glycoproteins are expressed,
surface-targeted and functional in DBCCs
It is plausible that the viral fusion machinery, which con-
sists of the fusion (F) and attachment (H) proteins, could be
involved in the direct intercellular transfer of CDV by
establishing pores between an infected and a target cell.
However, syncytia, an easily visible proof of cell–cell
fusion in cytolytic CDV infection [44], are absent in the
persistent infection. Therefore, following immunofluores-
cence demonstration of H and F expression in infected glial
cells (Fig. 6a, b), we further investigated whether both
glycoproteins were properly surface-expressed and func-
tional. To this aim, we engineered a lentivirus vector
expressing the canine CD150/SLAM receptor. The ratio-
nale behind this strategy was to assess whether rA75/17red
could mediate syncytia formation in SLAM-transduced
primary canine brain cells, which would reveal not only the
production of functional F/H complexes but also their
expression at the plasma membrane. As a transduction
control, DBCCs were initially transduced with a GFP-
expressing lentivirus. We noticed that the efficiency of
lentivirus transduction in DBCCs was rather low, yielding
a maximum of 5–10% of GFP-expressing cells (not
shown). Nevertheless, DBCCs were first infected with
SLAM-expressing (or empty) lentivirus vectors and cells
were super-infected with rA75/17red 3 days post-transduc-
tion. Strikingly, while in DBCCs transduced with the
control empty vector, no syncytia were detected throughout
the whole cell monolayer (Fig. 6c), small but clear syncytia
could be readily observed in SLAM-transduced, rA75/
17red-infected, DBCCs (Fig. 6d).
Combined, these results indicated that functional viral
fusogenic complexes were expressed at the plasma mem-
brane in non-cytolytic infection mediated by rA75/17red in
primary brain cells.
The receptor-binding protein H is required for viral
spread
The expression of functional fusion complexes on the cell
membrane by itself is not sufficient to induce cell–cell
fusion. The current model of paramyxovirus fusion and
pore formation mechanism suggests that upon host cell
receptor binding the attachment (H) protein triggers a
signal to the fusion (F) protein, which in turn dramatically
refolds to ultimately mediate membrane fusion activity [16,
17, 33]. Consistent with the notion that the receptor-bind-
ing H protein is central in the fusion model, we generated a
recombinant virus with the attachment protein gene
knocked out from the viral genome (rA75/17red Hko). This
strategy, however, requires the production of single-cycle
infectious virus to enable initial cell entry. We thus thought
Fig. 4 rA75/17red is defective in free particles formation in primary
canine brain cells. a DBCCs were infected with rA75/17red at an MOI
of 0.01 (as titrated in Vero-SLAM cells). At the indicated days post-
infection, cell-free (SN) and cell-associated viruses (CA) were
harvested and titrated. Virus titers were determined 3 dpi by counting
the number of virus-infected cells (RFP-expressing cells). The cells
were overlaid 2 h post-infection with medium containing 1% of soft
agar. Values represent the mean of three independent experiments.
b Virus entry efficiency. Vero-SLAM cells (V/S) and DBCCs were
infected with rA75/17red at an MOI of 0.01 (titrated in Vero-SLAM
cells). One day post-infection, the number of infected Vero-SLAM
cells and DBCCs per well were counted and are represented in the
graph
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to complement the particles by introducing H in trans using
Vero-SLAM cells that constitutively express the receptor-
binding H protein. The latter cells were obtained by
transducing Vero-SLAM cells with a lentivirus expressing
Hwt. Though the different resulting clones exhibited only
low level of H expression at the cell surface, most of the
Fig. 5 Ultrastructural images of DBCCs infected with A75/17-CDV.
a Large and small cell adjacent processes containing cross and
longitudinally sectioned tubular profiles of CDV nucleocapsids
(arrowheads). AF bundles of astrocytic fibrils (911,000). b Two
adjacent astroglial cell processes. In the cytosol of the left process
accumulation of ‘‘fuzzy’’ nucleocapsids (open arrowhead) close to
cell membrane with focal blurring of the adjacent cell membranes
between the two cells (915,000). c Two adjacent cell processes. The
upper process contains an electron-dense nucleocapsid aggregate.
Discontinuous plasmalemmal densities, ‘‘spiking’’ (filled arrow-
heads), distinction between adjacent cell membranes becomes less
clear in this area. Arrow depicts nearby gap junction (911,000).
d Cell process between two cell bodies containing electron-dense
nucleocapsid aggregates with tubular structures embedded in a
granular matrix (arrowheads) attached to the cell membrane
(911,000). e Several closely spaced cell processes, containing
nucleocapsid aggregates (open arrowheads). Several plasmalemmal
densities (grey arrowheads), one of which exhibits ‘‘spiking’’
morphology (double arrowhead) (911,000). f Low power composite
of four overlapping EM photographs showing an astrocyte with
nucleus (A1) and parts of the perikaryon of two further astrocytes
(A2, A3) all of which contain numerous nucleocapsid aggregates
(a few depicted by white arrowheads) (93,000). In addition, the
image shows several large and small cell processes equally containing
nucleocapsid aggregates and one large viral inclusion (double white
arrowhead). Small arrows depict a cell process connecting A2 and A3
with continuity between the cytoplasm of both perikarya
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clones elicited positive staining as determined by immu-
nofluorescence analysis (data not shown). This was
followed by limited dilution, which allowed us to select a
clone named Vero-SLAM-H. Flow cytometry analysis
using two different conformation-dependent anti-H MAbs
validated Hwt expression at the cell surface. Furthermore,
we also confirmed that SLAM was not dramatically down-
regulated (not shown). Hwt and SLAM functionalities were
finally assessed by transfecting Fwt in Vero-SLAM-H
cells. Indeed, cell–cell fusion activity was readily induced
(not shown).
Bsr-T7 cells [4] were used for transfection with the
different plasmids necessary and sufficient to initiate the
viral life cycle (pTM-N, P, L and the relevant full-length
cDNA [28]). Importantly, the expression plasmid encoding
the VSV glycoprotein G was added to the transfection
mixture. VSV-G was employed to pseudo-type CDV par-
ticles, in turn allowing the first transfer from Bsr-T7 to
Vero-SLAM-H cells in a VSV-G-dependent manner. Three
successive passages in Vero-SLAM-H cells were then
performed to amplify the H-knockout virus in the absence
of VSV-G. Using this strategy, we could successfully
rescue a virus that we named rA75/17red Hko/Hcomp, which
reached titers of about 1 9 104 viruses/ml.
To verify whether the newly recovered recombinant
virus was indeed trans-complemented by H but impaired in
H protein expression, Vero-SLAM and Vero-SLAM-H
cells were infected with wild-type rA75/17red or with rA75/
17red Hko/Hcomp, respectively. Immunofluorescence analy-
ses using the anti-H MAb (3900 [26]) were then performed
on fixed and permeabilized cells, 30 h post-infection.
Importantly, red fluorescence could be observed with both
viruses in Vero-SLAM and Vero-SLAM-H cells, indicating
that both viruses efficiently entered and replicated (Fig. 7b,
e, h, k). Moreover, this result supports the notion that H
was incorporated in the recombinant H-knockout virus’
envelope. As expected, rA75/17red efficiently produced the
receptor-binding H protein in both cell lines. Note that in
Vero-SLAM-H cells, all cells (infected and non-infected)
exhibited the anticipated positive staining for H. Con-
versely, in rA75/17red Hko/Hcomp-infected Vero-SLAM
cells, no H protein was detected at all by immunofluores-
cence analysis, whereas in Vero-SLAM-H cells positive
staining was observed (Fig. 7a, d, g, j). Furthermore,
in Vero-SLAM-H cells, rA75/17red Hko/Hcomp mediated
efficient syncytia formation thus validating proper F
expression, whereas in Vero-SLAM cells infection was
clearly restricted to the initially infected cell. Finally, anti-
H MAbs (3900 and 1347 [26]) neutralized both viruses in
both cell lines, confirming that H was anchored in both
virus’ envelopes and that F alone was not sufficient to
support viral cell entry in these cells (data not shown).
These results taken together validate that our newly
recovered H-knockout rA75/17-CDV was indeed impaired
in receptor-binding protein expression, while being trans-
complemented by a functional H protein.
DBCCs were thus infected either with rA75/17red or
with rA75/17red Hko/Hcomp at an MOI of 0.001. We con-
stantly obtained a mean of 10–50 infected cells throughout
the primary DBCCs with both recombinant viruses 1–
2 dpi. As expected, rA75/17red spread efficiently, since
viral foci originating from single initially infected cells
grew to more than 100 infected cells after 5–7 days of
infection (see Fig. 1a). Strikingly, however, rA75/17red
Hko/Hcomp was totally deficient in cell-to-cell transmission,
since viral infection remained restricted to the initially
infected cells (Fig. 8a–d). Importantly, the obvious absence
of diffusion of the RFP to contacting neighboring glial cells
from rA75/17red Hko/Hcomp-infected cells provided strong
evidence that potentially pre-existing astrocytic connec-
tions were insufficient to allow transfer of small molecules
such as RFPs, thereby excluding any spontaneous transfer
of large macromolecules such as viral nucleocapsids.
To confirm the above data, we sought to determine
whether MAbs directed against the receptor-binding H
Fig. 6 The CDV fusogenic complexes are potentially functional in
DBCCs. a, b Both CDV surface glycoproteins are properly expressed
in glial cells. DBCCs were infected with rA75/17red with an MOI of
0.01. Merged images of both glycoproteins F and H stained with anti-
F and anti-H antibodies, respectively, followed by secondary alexa
fluor 488-conjugated antibody (green) and astrocytes labeled using an
anti-GFAP antibody, followed by a secondary alexa fluor 555-
conjugated antibody (red). Confocal laser microscopy 9200. c, d F/H
complexes are cell surface targeted in potentially functional. Prior to
infection of DBCCs with rA75/17red (MOI of 0.01), cells were
transduced with a lentivirus vector expressing SLAM (pRRL-SLAM)
or with a control empty plasmid (pRRL). Syncytia formation was
readily observed in CDV-infected cells. No syncytia are demonstrated
in the control culture
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protein could also inhibit cell–cell transmission. Hence,
several MAbs were initially tested in F/H-transfected Vero-
SLAM cells to assess their potential to inhibit lateral cell–
cell fusion activity. One out of four anti-H MAbs was able
to strongly inhibit syncytia formation (MAb anti-H 1347
[26]). This antibody was thus tested in infected primary
canine brain cultures. While a control antibody (anti-HA)
did not influence rA75/17red spread in DBCCs throughout
the time of infection (Fig. 8e), the anti-H MAb 1347
strongly impaired viral cell–cell transmission (Fig. 8f), in
turn confirming the key role of CDV-H in governing the
non-cytolytic type of spread of virulent CDV in brain cells.
Taken together, this is the first demonstration for the
morbilliviruses that the hemagglutinin (H) protein is
strictly required for efficient viral spread in glial cells.
These results further suggest that CDV-mediated fusion
activity may be necessary to allow non-cytolytic cell-to-
cell spread in brain cells, in turn excluding direct transfer
of the nucleocapsid to neighboring cells through other pre-
existing intercellular channels.
Discussion
To investigate the mechanism of viral cell-to-cell spread
leading to persistence and chronic progressive demyelina-
tion [39], we used primary canine brain cell cultures
combined with a molecularly cloned CDV, engineered to
express an additional RFP, but otherwise identical in
sequence to a virulent and demyelinating morbillivirus
strain. Our results indicate that cell-to-cell spread does not
require budding particles as in traditional viral life cycle
models of CDV transmission [12]. Indeed, titration
experiments demonstrated that persistent CDV in glial cells
produces extremely low levels of free progeny viruses,
which furthermore had very low entry efficiencies in
Fig. 7 Characterization of the
recombinant Hko rA75/17red
virus. Vero-SLAM (a–f) and
Vero-SLAM-H cells (g–i) were
infected with rA75/17red and
rA75/17red/Hko/Hcomp. One day
post-infection, both cells were
fixed, permeabilized and stained
using the anti-H MAb 1C42H11
(VMRD) to detect the CDV
hemagglutinin protein. This was
followed by addition of an alexa
fluor 488-conjugated secondary
antibody. In addition, auto-
fluorescence of the RFP is also
shown, which allowed us for a
direct illumination of infected
cells. Merged images are also
represented (c, f, i and l).
Fluorescent images were taken
using a confocal scanning laser
microscope (Olympus) (9200)
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DBCCs. Moreover, agar overlay of the cultures did not
impair spread and electron microscopic examination
illustrated ample presence of viral nucleocapsids in infec-
ted cells but extremely rare signs of budding or free viral
particles. In addition, in an unanticipated manner, we
demonstrated that consecutive spread between cells can
happen within 5–6 h. It is interesting to note in this respect
that Duprex and collaborators [7] demonstrated spread of
MV in astrocytoma cell lines in a time frame of 4–5 h.
These observations are hard to reconcile with the fact that
it takes about 24 h for CDV to enter a cell, replicate, and
release progeny particles to infect a new cell [12]. Taken
together, these results strongly argue against extracellular
transfer of viral particles as a way how persistent CDV is
transmitted in astrocytes. Since at any time point all
infected cells in a given area always seemed to be in
contact with each other by way of their processes, direct
intracellular transfer of infectious material between astro-
cytes is suggested.
Since spontaneous diffusion of RFP did not occur in
non-infected, RFP-transfected (not shown) and, most
importantly, in rA75/17red Hko/Hcomp-infected canine brain
cell cultures, pre-existing channels between normal astro-
cytes, if such exist at all, are presumably not employed for
nucleocapsid transfer from one cell to another. Thus, we
have to assume that the infection itself could induce such
channels. This could happen using the morbillivirus
membrane fusion machinery even though clear evidence
for cell–cell fusion in the form of multinucleated syncytia
is completely lacking in persistent CDV infection. Never-
theless, we demonstrated that persistent CDV expressed
functional fusogenic complexes, which consist of the
fusion (F) and attachment (H) glycoproteins at the plasma
membrane of glial cells. These could only induce fusion
following binding of the fusion complex to the viral
receptor. We documented that such binding presumably
took place since an H-knockout recombinant virus was
totally defective in viral spread and treatment of infected
cells with a monoclonal anti-H antibody dramatically
reduced lateral cell-to-cell transmission. This is the first
demonstration for CDV that persistent cell-to-cell spread in
primary canine brain cells is very likely dependent on the
receptor-binding H protein. Consequently, according to the
current morbillivirus-induced fusion model, potential cell–
cell fusion events would then require proper expression of
a cellular receptor on target cells. Since we found that the
universal Morbillivirus CD150/SLAM receptor was not
expressed in glial cells, these results suggest the existence
of a hitherto unknown CDV receptor on glial cells neces-
sary to allow CDV intracellular spread. This stands in sharp
contrast to persistent MV infection in rat neuronal cells,
where non-cytolytic cell-to-cell viral transmission has been
reported to depend on a target receptor for the initial cell
entry but not for subsequent lateral spread [20]. On the
other hand, we cannot definitely rule out that H is only
required to bind a target receptor, in turn generating pores
in an F-independent manner, or that H is necessary to help
F to be transported to the cell surface in its potentially
functional pre-fusion conformational state.
Taken together, our findings are suggestive for fusion
activity induced by CDV between infected and target cells,
which presumably result from the combination of the
fusion complex and a viral receptor, to enable the virulent
virus to spread in glial cells. However, since multinucle-
ated cells were not observed in CDV-infected cells, fusion
activity presumably must be limited to small areas of the
cell membrane by some unknown molecular mechanisms.
We thus hypothesize that only micro-fusion events are
mediated by virulent CDV in infected glial cells. Such
micro-fusion events have been postulated to occur in MV
Fig. 8 Role of the receptor-binding H protein in viral spread. a–d
Infection of DBCCs with a hemagglutinin (H) knockout, H trans-
complemented recombinant A75/17 virus (rA75/17red/Hko/Hcomp).
The latter recombinant virus required initial trans-complementation
with the wild-type hemagglutinin (Hwt) protein in Vero-SLAM cells
stably expressing Hwt (Vero-SLAM-H cells). The four images taken
at 3, 6, 9 and 12 dpi of the same infected focus illustrated no further
spread from the initially infected cells. Infected cells were identified
by capturing red fluorescence emission using a confocal laser
microscope. e, f DBCCs infected with rA75/17red and treated with
an antibody against H (MAb 1347 [26]) exhibited markedly fewer
infected cells as compared to cultures treated with a control antibody
(MAb anti-HA). Infected cells were identified by capturing red
fluorescence emission using a confocal laser microscope
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infection in vitro [7, 9, 10] but have never been clearly
demonstrated.
Confocal microscopical images of infected DBCCs in
the present study were suggestive of continuity between
infected cells by way of thin connecting cell processes,
often containing nucleocapsids even in the thinnest astro-
cytic ramifications, as detected by electron microscopy and
immunofluorescence analysis. Confirmation of continuity
between infected cells with the electron microscope
remains anecdotical because of low probability to cut two
remote cells and a connecting cell process in the same
plane of section. Other signs that could be indicative of
membrane fusion activity included focal plasmalemmal
densities or ‘‘spiking’’ of the viral glycoproteins, attach-
ment of nucleocapsids to the cell membrane, and
occasionally, blurring of the borders of opposing cell
membranes. While unequivocal morphological demon-
stration of micro-fusion events based on static images
remains elusive, their existence is, however, supported by
our functional assays demonstrating that H was essential
for CDV spread, in turn suggesting that the viral fusion
complex was indeed of importance.
Our dynamic studies in living cultures clearly showed
that viral transmission between infected and target cells
occurred specifically at the tips of astrocytic processes.
Therefore, CDV was rarely transmitted to immediately
adjacent cells, even though DBCCs are completely con-
fluent and often multilayered. Consequently, CDV spread
obviously takes place along cell processes to remote cells
bypassing numerous others, which remained uninfected,
carrying the infection over large distances in the culture.
While our observations explain why viral spread is indeed
selective, as previously proposed in CDV [39] and in MV
[8], how could the postulated micro-fusion events occur
only in these very limited areas of the cell membrane? This
might be related to specific cell membrane targeting of the
viral glycoproteins as described in MV [23] or restricted
distribution of the putative, yet unidentified, glial CDV
receptor, perhaps similar to viral receptor clustering
directing fusion in MV [35]. However, the extremely
restricted targeting of the postulated viral fusion events in
our study suggests that cellular factors must be involved.
Selective spread of CDV in astrocytes is reminiscent of
MV infections in selected neuronal networks using existing
neuronal transport mechanisms or functional connections
to spread [9, 21]. In ferrets, CDV can also use neuronal
pathways to enter and spread in the brain [32]. However,
specific to CDV in dogs and relevant to the demyelinating
process is the infection of white matter astrocytes, the main
target of CDV in vivo and in vitro [39]. Akin to neurons,
astrocytes also establish communication networks in which
gap junctions play a synapse-like role [14]. Since inter-
cellular junctions have been shown to promote viral egress
in other viral systems [13], it is quite possible that CDV
uses perhaps the gap junctions, which are indeed concen-
trated at the tip of processes [31], to spread in the astrocytic
syncytial network. How the viral fusion complex and its
receptor interact with such astrocytic factors is subject of
future work.
In conclusion, our findings indicated that persistent
CDV infection can spread from cell-to-cell without using
free viral particles. Moreover, our data suggested that
spread probably requires interaction of the viral attachment
protein at the surface of an infected cell with a yet
unidentified glial cellular receptor on target cell. Although
other mechanisms cannot be excluded, it seems reasonable
to assume that this binding triggers the fusion protein to
establish micro-pores between infected and target cells,
allowing transfer of viral nucleocapsids.
Although it is thought that non-cytolytic cell-to-cell
spread of viruses evolved to escape immune detection [34],
CDV in the CNS is readily detected by the immune system
[39]. Therefore, the neuropathology of distemper enceph-
alitis is characterized by intense inflammation with
clearance of the virus. It is important to note that this
process is restricted to focal areas of the white matter.
However, coexisting with and outside of these inflamma-
tory plaques, clusters of infected astrocytes are found, thus
showing continuing viral spread despite an effective
intrathecal anti-viral immune response [39]. Our present
findings may shed some light on this phenomenon which is
clearly responsible for the chronic progression of the dis-
ease. They show that CDV can spread rapidly in the
astrocytic network. By the time an effective immune
response is mounted in an infected area, the virus is already
carried away from the focus of anti-viral attack. Thus, viral
persistence in CDV infection may be explained by a
strategy of ‘‘outrunning’’ the immune response.
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